Symmetry Partner »

Neurocrine Biosciences shares owned by Symmetry Partner

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Symmetry Partner from 13F filings

Historical chart of Symmetry Partner investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Symmetry Partner consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Symmetry Partner

Quarter filed Position value Share count Share price at filing
2023-12-31 $246k 1.9k 131.97

More positions owned by Symmetry Partner

Vanguard Small-Cap Value Etf (VBR)
Vanguard Total International Bond Etf (BNDX)
iShares MSCI USA Momentum Factor Etf (MTUM)
Vanguard Total Stock Market Etf (VTI)
Vanguard Total Bond Market Etf (BND)
iShares MSCI USA Min Vol Factor Etf (USMV)
iShares MSCI EAFE Value Etf (EFV)
Vanguard Value Etf (VTV)
Vanguard FTSE All-Wld ex-US SmCp Etf (VSS)
Dimensional US Marketwide Value Etf (DFUV)
iShares National Muni Bond Etf (MUB)
Vanguard Short-Term Bond Etf (BSV)
Vanguard FTSE Developed Markets Etf (VEA)
iShares MSCI USA Quality Factor Etf (QUAL)
Vanguard FTSE Emerging Markets Etf (VWO)

View all positions for Symmetry Partner

Top funds holding Neurocrine Biosciences

BlackRock
Vanguard Group
Bellevue Group
Jpmorgan Chase & Co
Geode Capital Management
Henderson Group
T. Rowe Price Associates
Point72 Asset Management
Dodge & Cox
Wellington Management Company
DSM Capital Partners
Brown Advisory Holdings Incorporated
Pictet Asset Management Holding SA
Rock Springs Capital Management
Bank of New York Mellon

View all funds holding Neurocrine Biosciences